| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.4 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.4 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |